Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pharmacokinetic and Safety Assessment of G3139 Administered by Subcutaneous Injection to Patients With Solid Tumors

NCT00543231 is registered in ClinicalTrials.gov with Genta Incorporated as lead sponsor.

NCT NCT00543231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00543231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pharmacokinetic and Safety Assessment of G3139 Administered by Subcutaneous Injection to Patients With Solid Tumors
Lead sponsor
Genta Incorporated
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2005
Completion date
December 31, 2006
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tumors